The FDA has approved Keytruda in combination with pemetrexed and platinum chemotherapy, as first-line Tx of unresectable advanced or metastatic malignant pleural mesothelioma.

Merck & Co. said a European Medicines Agency panel recommended expanded approval of the drugmaker's blockbuster cancer treatment Keytruda in two types of gynecologic cancers.

TriLite, the developer of the world's smallest projection display, has successfully completed an extended Series A funding round, raising its total Series A funding to more than ?20 million. This ...

Apple's on-device generative AI capability is a unique competitive advantage powered by Apple Silicon. Read why I have an ...

no other medicine has outperformed Keytruda in a late-stage lung cancer study — one reason why Merck’s therapy has become one of the most lucrative pharmaceutical products in the decade since ...

Merck’s Keytruda Combo for Urothelial Carcinoma Gets EU Approval: The European Commission granted approval to Merck’s Keytruda in combination with Astellas/Pfizer’s antibody-drug conjugate ...

Our list of best-selling baby products is fun as well as functional, and generally a lifesaver for totally exhausted parents who don’t have the time to test out dozens of products to find the best one ...

Credit: R Photography Background/Shutterstock. Merck & Co has received European Commission (EC) approval for the use of Keytruda (pembrolizumab ... recommendation from the Committee for Medicinal ...

Its four-year dividend yield is 2.90%. MRK’s sales for the second quarter ended June 30, 2024, increased 7.2% year-over-year to $16.11 billion, while its KEYTRUDA product sales improved by 15.9% from ...

Merck faces significant challenges, including increased competition and regulatory scrutiny for Keytruda. Keytruda is facing potential threats from competitors like Summit Therapeutics ...

To help you prepare for colder weather, these health products boost your immune system and help you relax. Anyone who suffers from seasonal allergies, frequently gets colds or deals with seasonal ...